4.6 Article

Annexin A2 Reduces PCSK9 Protein Levels via a Translational Mechanism and Interacts with the M1 and M2 Domains of PCSK9

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Biochemistry & Molecular Biology

An Antibody against the C-Terminal Domain of PCSK9 Lowers LDL Cholesterol Levels In Vivo

Felix Schiele et al.

JOURNAL OF MOLECULAR BIOLOGY (2014)

Review Biochemistry & Molecular Biology

Annexin A2 Heterotetramer: Structure and Function

Alamelu Bharadwaj et al.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)

Review Biochemistry & Molecular Biology

Multiple Roles of Annexin A2 in Post-Transcriptional Regulation of Gene Expression

Anni Vedeler et al.

CURRENT PROTEIN & PEPTIDE SCIENCE (2012)

Review Biotechnology & Applied Microbiology

The biology and therapeutic targeting of the proprotein convertases

Nabil G. Seidah et al.

NATURE REVIEWS DRUG DISCOVERY (2012)

Article Multidisciplinary Sciences

Annexin A2 Is a Natural Extrahepatic Inhibitor of the PCSK9-Induced LDL Receptor Degradation

Nabil G. Seidah et al.

PLOS ONE (2012)

Article Biochemistry & Molecular Biology

Annexin A2 and PSF proteins interact with p53 IRES and regulate translation of p53 mRNA

Arandkar Sharathchandra et al.

RNA BIOLOGY (2012)

Article Biochemistry & Molecular Biology

In Vivo Evidence That Furin from Hepatocytes Inactivates PCSK9

Rachid Essalmani et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2011)

Article Biochemistry & Molecular Biology

A PCSK9-binding antibody that structurally mimics the EGF(A) domain of LDL-receptor reduces LDL cholesterol in vivo

Yan G. Ni et al.

JOURNAL OF LIPID RESEARCH (2011)

Article Biochemistry & Molecular Biology

Role of the C-terminal domain of PCSK9 in degradation of the LDL receptors

Oystein L. Holla et al.

JOURNAL OF LIPID RESEARCH (2011)

Review Biochemistry & Molecular Biology

Effects of currently prescribed LDL-C-lowering drugs on PCSK9 and implications for the next generation of LDL-C-lowering agents

Robert J. Konrad et al.

LIPIDS IN HEALTH AND DISEASE (2011)

Article Biochemistry & Molecular Biology

Effects of the Prosegment and pH on the Activity of PCSK9 EVIDENCE FOR ADDITIONAL PROCESSING EVENTS

Suzanne Benjannet et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Biochemistry & Molecular Biology

A new method for measurement of total plasma PCSK9: clinical applications

Genevieve Dubuc et al.

JOURNAL OF LIPID RESEARCH (2010)

Article Endocrinology & Metabolism

Disrupted recycling of the low density lipoprotein receptor by PCSK9 is not mediated by residues of the cytoplasmic domain

Thea Bismo Strom et al.

MOLECULAR GENETICS AND METABOLISM (2010)

Review Pharmacology & Pharmacy

PCSK9 as a therapeutic target of dyslipidemia

Nabil G. Seidah

EXPERT OPINION ON THERAPEUTIC TARGETS (2009)

Article Multidisciplinary Sciences

A proprotein convertase subtilisin/kexin type 9 neutralizing antibody reduces serum cholesterol in mice and nonhuman primates

Joyce C. Y. Chan et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)

Article Cardiac & Cardiovascular Systems

Berberine decreases PCSK9 expression in HepG2 cells

Jamie Cameron et al.

ATHEROSCLEROSIS (2008)

Article Biochemistry & Molecular Biology

Annexin A2 Is a C-terminal PCSK9-binding Protein That Regulates Endogenous Low Density Lipoprotein Receptor Levels

Gaetan Mayer et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2008)

Article Multidisciplinary Sciences

Molecular basis for LDL receptor recognition by PCSK9

Hyock Joo Kwon et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Multidisciplinary Sciences

Structural requirements for PCSK9-mediated degradation of the low-density lipoprotein receptor

Da-Wei Zhang et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemistry & Molecular Biology

Secreted PCSK9 promotes LDL receptor degradation independently of proteolytic activity

Jun Li et al.

BIOCHEMICAL JOURNAL (2007)

Article Biochemistry & Molecular Biology

Effects of pH and low density lipoprotein (LDL) on PCSK9-dependent LDL receptor regulation

Timothy S. Fisher et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2007)

Article Biochemistry & Molecular Biology

Secreted PCSK9 downregulates low density lipoprotein receptor through receptor-mediated endocytosis

Yue-Wei Qian et al.

JOURNAL OF LIPID RESEARCH (2007)

Article Biochemistry & Molecular Biology

Structural and biophysical studies of PCSK9 and its mutants linked to familial hypercholesterolemia

David Cunningham et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2007)

Article Medicine, Research & Experimental

Secreted PCSK9 decreases the number of LDL receptors in hepatocytes and in livers of parabiotic mice

Thomas A. Lagace et al.

JOURNAL OF CLINICAL INVESTIGATION (2006)

Article Biochemistry & Molecular Biology

Annexin A2 recognises a specific region in the 3′-UTR of its cognate messenger RNA

Hanne Hollas et al.

BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2006)

Article Genetics & Heredity

A spectrum of PCSK9 Alleles contributes to plasma levels of low-density lipoprotein cholesterol

IK Kotowski et al.

AMERICAN JOURNAL OF HUMAN GENETICS (2006)

Article Multidisciplinary Sciences

Decreased plasma cholesterol and hypersensitivity to statins in mice lacking Pcsk9

S Rashid et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Multidisciplinary Sciences

Overexpression of PCSK9 accelerates the degradation of the LDLR in a post-endoplasmic reticulum compartment

KN Maxwell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)

Article Biochemistry & Molecular Biology

Annexin A2 binds to the localization signal in the 3 ' untranslated region of c-myc mRNA

I Mickleburgh et al.

FEBS JOURNAL (2005)

Article Biochemistry & Molecular Biology

Annexin A2 is a novel RNA-binding protein

NR Filipenko et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2004)

Article Multidisciplinary Sciences

Adenoviral-mediated expression of Pcsk9 in mice results in a low-density lipoprotein receptor knockout phenotype

KN Maxwell et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Genetics & Heredity

Mutations in PCSK9 cause autosomal dominant hypercholesterolemia

M Abifadel et al.

NATURE GENETICS (2003)

Article Multidisciplinary Sciences

The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1):: Liver regeneration and neuronal differentiation

NG Seidah et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)

Article Biochemistry & Molecular Biology

Annexin II is associated with mRNAs which may constitute a distinct subpopulation

A Vedeler et al.

BIOCHEMICAL JOURNAL (2000)

Article Biochemical Research Methods

Comparative characterization of two forms of recombinant human SPC1 secreted from Schneider 2 cells

JB Denault et al.

PROTEIN EXPRESSION AND PURIFICATION (2000)